See ratings and reviews when you sign up for an account.

Northwestern Ovarian Cancer Early Detection & Prevention Program

This study is currently Recruiting

February 2011 By Northwestern University

First Recieved on April 6, 2000

Last Updated on February 25, 2011

Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)
Information provided by: Northwestern University
Identifier: NCT00005095


RATIONALE: Screening may help doctors find ovarian cancer sooner, when it may be easier to treat. It may also help doctors plan better treatment for ovarian cancer. PURPOSE: This clinical trial is studying screening methods for identifying women who are at increased risk for developing ovarian cancer.

Study Type: Observational
Study Design: Time Perspective: Prospective


Ages Eligible for Study:18 Years
Genders Eligible for Study:Female
Accepts Healthy Volunteers:No

DISEASE CHARACTERISTICS: - Meets one of the following criteria: - Asymptomatic AND considered to be at increased risk for developing ovarian cancer, as defined by one of the following: - Personal history of breast or colon cancer - Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer - Has a personal or family history of hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome) - Has at least two family members with breast, ovarian, primary peritoneal, fallopian tube, uterine, and/or pancreatic cancer - Undergoing surgery for a gynecologic condition, including any of the following: - Diagnosis of a reproductive cancer - Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts) - Highly suspicious adnexal mass - Risk-reducing prophylactic oophorectomy PATIENT CHARACTERISTICS: Age - 18 and over


  • Investigator: Lee P. Shulman, MD - Study Chair - Robert H. Lurie Cancer Center


  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Chicago, Illinois 60611-3013 United States

Conditions related to this trial:

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.